- #1184513
- Glaxo Specialty #49401008847
Benlysta® Belimumab 200 mg / mL Injection Prefilled Syringe 4 per Box
BENLYSTA, SYR 200MG/ML (4/BX)
Features
- BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
- BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.
- BENLYSTA (belimumab) injection is a clear to opalescent, and colorless to pale yellow solution for subcutaneous use. Each single-dose prefilled syringe is designed to deliver 200 mg of belimumab in 1 mL of solution and is supplied as follows: 200 mg/mL single-dose prefilled glass syringe with 27-gauge, half-inch needle attached in a carton of 4 (NDC 49401-088-47).
- More …
Product Details Email
Product Specifications
McKesson # | 1184513 |
Manufacturer # | 49401008847 |
Brand | Benlysta® |
Manufacturer | Glaxo Specialty |
Country of Origin | Unknown |
Application | Immunosuppressive Agent |
Container Type | Prefilled Syringe |
Dosage Form | Injection |
Generic Drug Name | Belimumab |
NDC Number | 49401008847 |
Product Dating | McKesson Acceptable Dating: we will ship >= 180 days |
Quantity | 4 per Box |
Storage Requirements | Requires Refrigeration |
Strength | 200 mg / mL |
Type | Subcutaneous |
UNSPSC Code | 51202403 |
Features
- BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
- BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.
- BENLYSTA (belimumab) injection is a clear to opalescent, and colorless to pale yellow solution for subcutaneous use. Each single-dose prefilled syringe is designed to deliver 200 mg of belimumab in 1 mL of solution and is supplied as follows: 200 mg/mL single-dose prefilled glass syringe with 27-gauge, half-inch needle attached in a carton of 4 (NDC 49401-088-47).
- Requires Refrigeration
Professionals Also Viewed
- #739927
- Sandoz #00781210201
No Image
- #1164023
- American Health Packaging #68084045001
- #795875
- Roche #00004029809
- 500 mg mycophenolate mofetil in a 20 mL sterile single-dose vial carto …
- #897151
- Novartis #00078024615